ScripIndustry anxiety is riding high as pharmaceutical manufacturers wait to hear from US president Donald Trump about whether or not drugs will be included in the next round of tariffs to be announced on
Pink SheetAnxiety is high as pharmaceutical manufacturers wait to hear from President Trump about whether or not drugs will be included in the next round of tariffs to be announced on 2 April. Trump is expected
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Dr. Reddy’s Acquires Rights From
Pink Sheet“Pipeline in a pill”-style drug development will be on display in April, when more than half of the user fee goal dates are for new indications on sometimes sprawling labels, as well as one novel biol